AI assistant
Sending…
Riot Platforms, Inc. — Director's Dealing 2010
Mar 26, 2010
30793_dirs_2010-03-26_e207d9a1-e5e7-4e2d-a6a9-0e980975242e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2010-03-24
Reporting Person: Lundy Steve (Director, CEO and President)
More from Riot Platforms, Inc.
Annual Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 4
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 5